Fingolimod and liver injury research information (PubMed) on: November 01, 2019, 06:08:19 pm #1 From PubMed, the Overview section on fingolimod in the report entitled LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, issued by the National Institute of Diabetes and Digestive and Kidney Diseases: Fingolimod Fingolimod is an orally available sphingosine-1-phosphate (S1P) receptor modulator that acts as an immunomodulatory drug and is used to treat relapsing multiple sclerosis. Fingolimod is associated ... NCBI Bookshelf · ncbi.nlm.nih.gov Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
